KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Total Non-Current Liabilities (2016 - 2026)

Emergent BioSolutions has reported Total Non-Current Liabilities over the past 17 years, most recently at $755.6 million for Q1 2026.

  • For Q1 2026, Total Non-Current Liabilities fell 9.83% year-over-year to $755.6 million; the TTM value through Mar 2026 reached $755.6 million, down 9.83%, while the annual FY2025 figure was $742.1 million, 14.48% down from the prior year.
  • Total Non-Current Liabilities for Q1 2026 was $755.6 million at Emergent BioSolutions, up from $742.1 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $1.7 billion in Q4 2022 and troughed at $742.1 million in Q4 2025.
  • A 5-year average of $1.1 billion and a median of $1.1 billion in 2024 define the central range for Total Non-Current Liabilities.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 43.51% in 2023 and later plummeted 35.48% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $1.7 billion in 2022, then tumbled by 34.09% to $1.1 billion in 2023, then dropped by 24.21% to $867.8 million in 2024, then fell by 14.48% to $742.1 million in 2025, then rose by 1.82% to $755.6 million in 2026.
  • Business Quant data shows Total Non-Current Liabilities for EBS at $755.6 million in Q1 2026, $742.1 million in Q4 2025, and $835.9 million in Q3 2025.